

Every clinician in the NHS works with a gap between what national guidance recommends and what happens on a busy ward at three in the afternoon. Guidance exists in abundance. Time to find it does not. A two-year partnership between Manchester University NHS Foundation Trust and the National Institute for Health and Care Excellence sets out to narrow that gap by placing the evidence inside the electronic patient record itself, and the idea deserves attention well beyond Greater Manchester.
The centrepiece is a NICE guidance agent, to be tested within Hive, the trust's electronic patient record system. Doctors and nurses would receive relevant evidence and treatment advice within their standard digital workflows, rather than leaving the record to search external databases or recall a recommendation from memory. For a workforce stretched by operational pressure, removing even a few minutes of searching per decision is a meaningful gain, and consistent application of guidance is a long-standing goal of national policy.
The second objective is less visible but may prove more consequential. The collaboration will gather real-world clinical data to help NICE evaluate promising health technologies and update future guidance more quickly. Evaluation of new technologies has often depended on trial evidence that arrives slowly and reflects conditions unlike routine practice. Data drawn from a large teaching trust, collected as care is delivered, offers a faster and more representative route. NICE regards the trust's digital and research infrastructure as an ideal testing ground, and the choice is credible. Mark Cubbon, the trust's chief executive, has stressed that the aim is a blueprint capable of being scaled across the wider NHS.
That ambition rests on groundwork already laid. Manchester has been extending Hive across its local care organisations, supported by a new digital and data academy and a secure analytics platform. The programme completed its initial mobilisation, known as Phase 0, in June. It is now in Phase 1, in which frontline subject matter experts help refine the system design, ahead of a scheduled go-live in October 2027. Involving clinicians at this stage matters. Digital programmes in the NHS have too often foundered when systems were built for clinicians rather than with them, and a design shaped by those who will use it gives the guidance agent a better chance of being trusted and used.
The pilot also sits within a wider pattern at the trust. Manchester is working separately with the Medicines and Healthcare products Regulatory Agency on a health innovation sandbox, a controlled setting in which new tools can be tested under regulatory oversight. One application is the testing of tools that flag patients at high risk of complications from chronic illnesses. Taken together, the two partnerships give a single organisation a relationship with both the body that appraises technologies and the body that regulates them, which shortens the distance between a promising product and a patient who might benefit.
The timing is favourable. Government reform plans lean heavily on digital transformation, a shift towards prevention and a more productive use of existing capacity. Waiting lists remain high, workforce numbers are under strain, and the public expects a health service that adopts proven advances without delay. Tools that put guidance in front of clinicians at the point of decision speak directly to those expectations, and tools that generate evidence during routine care could reduce the lag that frustrates both patients and industry.
Several practical implications follow. NHS leaders elsewhere will want to watch how the agent performs in daily use, in particular whether clinicians act on its advice and whether outcomes or consistency improve. Policymakers have a chance to learn how national bodies and local providers can share data and responsibility under clear governance. Health-tech and life sciences companies gain a clearer view of how evidence might be generated for their products in real clinical settings. Patients stand to benefit from care that more reliably reflects current recommendations.
Success will depend on measurement. A pilot that reports honestly on usability, safety and effect on practice will be far more useful than one that simply demonstrates the technology works. If Manchester and NICE publish those findings, the partnership could give the NHS something it has long needed: a tested model for turning national evidence into routine local action, at the pace patients are entitled to expect.